Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date Filed: October 30, 2018
Reporting Period: Third quarter ended September 30, 2018
Context: This filing announces the Company's third-quarter 2018 results via a press release furnished as Exhibit 99.1, with corresponding financial figures in Exhibit 99.2.
Key Financial Metrics
The filing text serves as a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached Exhibits (99.1 and 99.2).
The Company utilizes the following non-GAAP financial measures to supplement IFRS results:
- EBITDA (Operating income excluding interest, taxes, depreciation, and amortization)
- Delivered operating income (Earnings before interest and taxes)
- Free cash flow
- Results presented in constant currency
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release and financial exhibits for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The Company states that non-GAAP measures are provided to enhance understanding of current performance and future prospects, ensuring consistency with prior reporting periods. These measures are not intended to substitute for GAAP/IFRS measures.
Regulatory Note: The attached exhibits are not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and are not subject to the liabilities of that section.
Guidance and Risks: The filing text does not contain specific forward-looking guidance, risk factors, or details on contingencies and unusual items.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2018 revenue, EBITDA, and free cash flow figures.
- Examine Exhibit 99.2 for the reconciliation of non-GAAP measures to IFRS financial measures.
- Verify the impact of currency fluctuations by comparing reported results with constant currency results.
- Confirm the specific debt levels and liquidity position in the attached financial statements, as they are not listed in this cover document.